{"id":6548,"date":"2023-03-16T02:48:34","date_gmt":"2023-03-16T02:48:34","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6548"},"modified":"2023-08-29T18:01:27","modified_gmt":"2023-08-29T18:01:27","slug":"prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6548","title":{"rendered":"Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9"},"content":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8 Prescient Therapeutics (ASX: PTX) \u5ba3\u5e03\u4e86\u9488\u5bf9\u590d\u53d1\u548c\u8010\u836f T \u7ec6\u80de\u6dcb\u5df4\u7624 (TCL) \u7684 PTX-100 1b \u671f\u6269\u5c55\u961f\u5217\u7684\u8fde\u7eed\u4e14\u79ef\u6781\u7684\u7ed3\u679c\u3002<\/p>\n<p>\u8be5\u7814\u7a76\u7531\u58a8\u5c14\u672c Epworth \u533b\u9662\u7684\u8457\u540d\u8840\u6db2\u5b66\u5bb6 H Miles Prince \u6559\u6388\u9886\u5bfc\uff0c\u5df2\u8bc1\u660e\u5177\u6709\u826f\u597d\u7684\u4e34\u5e8a\u6d3b\u6027\u548c\u51fa\u8272\u7684\u5b89\u5168\u6027\u3002<\/p>\n<p>\u81ea 2022 \u5e74 11 \u6708\u7684\u6700\u540e\u4e00\u6b21\u66f4\u65b0\u4ee5\u6765\uff0c\u5728\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624 (PTCL) \u60a3\u8005\u4e2d\u89c2\u5bdf\u5230\u4e24\u4e2a\u65b0\u7684\u5b8c\u5168\u53cd\u5e94\u3002<\/p>\n<p>\u6b64\u5916\uff0c10 \u540d\u53ef\u8bc4\u4f30\u60a3\u8005\u4e2d\u6709 7 \u540d\u7684\u53cd\u5e94\u6301\u7eed\u65f6\u95f4\u8d85\u8fc7\u62a4\u7406\u6807\u51c6\uff0c\u5df2\u62a5\u544a\u7684\u5b89\u5168\u72b6\u51b5\u4ecd\u7136\u201c\u975e\u5e38\u597d\u201d\u3002<\/p>\n<h2>\u7814\u7a76\u6210\u679c<\/h2>\n<p>PTX-100 \u5df2\u7528\u4e8e 13 \u540d TCL \u60a3\u8005\uff0c\u5176\u4e2d 8 \u540d\u60a3\u6709 PTCL\uff0c5 \u540d\u60a3\u76ae\u80a4 T \u7ec6\u80de\u6dcb\u5df4\u7624 (CTCL)\u3002<\/p>\n<p>\u5728 2,000mg\/m2 \u7684\u6700\u9ad8\u5242\u91cf\u4e0b\uff0cPTX-100 \u7ee7\u7eed\u8868\u73b0\u51fa\u201c\u51fa\u8272\u7684\u5b89\u5168\u6027\u201d\uff0c\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\u6781\u5c11\u3002<\/p>\n<p>\u4e00\u4e9b\u60a3\u8005\u51fa\u73b0\u4e86 3 \u7ea7\u4e0d\u826f\u4e8b\u4ef6\uff0c\u5305\u62ec\u4e2d\u6027\u7c92\u7ec6\u80de\u51cf\u5c11\u3001\u8840\u5c0f\u677f\u51cf\u5c11\u548c\u8d2b\u8840\uff0c\u8fd9\u53ef\u80fd\u4e0e PTX-100 \u6709\u5173\u3002 \u7136\u800c\uff0c\u8fd9\u4e9b\u4e0d\u826f\u4e8b\u4ef6\u5df2\u7ecf\u89e3\u51b3\u5e76\u4e14\u88ab\u8ba4\u4e3a\u662f\u53ef\u63a7\u7684\u3002<\/p>\n<p>\u5c3d\u7ba1\u5f53\u524d\u7814\u7a76\u7684\u4e3b\u8981\u76ee\u6807\u662f\u8bc4\u4f30\u5b89\u5168\u6027\uff0c\u4f46 Prescient \u79f0\uff0c\u4e0e\u5f53\u524d\u62a4\u7406\u6807\u51c6\u76f8\u6bd4\uff0c PTX-100 \u5728\u8fd9\u4e00\u96be\u4ee5\u6cbb\u7597\u7684\u60a3\u8005\u7fa4\u4f53\u4e2d\u7684\u4e34\u5e8a\u6d3b\u6027 \u201c\u4ee4\u4eba\u9f13\u821e\u201d\u3002<\/p>\n<p>\u7ee7\u8fd9\u4e9b\u6301\u7eed\u7684\u201c\u4ee4\u4eba\u9f13\u821e\u7684\u7ed3\u679c\u201d\u4e4b\u540e\uff0c\u76d1\u7ba1\u987e\u95ee\u5efa\u8bae Prescient \u518d\u62db\u52df\u4e03\u540d\u60a3\u8005\uff0c\u4ee5\u4fbf\u4e3a\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u7684\u4f1a\u8bae\u521b\u5efa\u66f4\u5f3a\u5927\u7684\u6570\u636e\u5305\u3002<\/p>\n<h2>\u53ef\u80fd\u52a0\u6025\u7684 FDA \u6279\u51c6<\/h2>\n<p>\u8be5\u516c\u53f8\u6253\u7b97\u5411 FDA \u63d0\u4ea4\u7533\u8bf7\u4ee5\u52a0\u901f\u6279\u51c6\u5b64\u513f\u836f\u5ba1\u6279\uff0c\u5982\u679c\u83b7\u5f97\u6279\u51c6\uff0c\u53ef\u80fd\u4f1a\u52a0\u5feb PTX-100 \u7684\u76d1\u7ba1\u7a0b\u5e8f\u3002<\/p>\n<p>\u5982\u679c\u672a\u83b7\u5f97\u52a0\u901f\u6279\u51c6\uff0c\u5219\u5c06\u6309\u7167\u6807\u51c6\u836f\u7269\u5f00\u53d1\u7a0b\u5e8f\u8fdb\u884c 2 \u671f\u8bd5\u9a8c\u3002<\/p>\n<p>\u6839\u636e FDA \u7684 Optimus \u9879\u76ee\uff0cPrescient \u5c06\u8981\u6c42\u6f84\u6e05 2 \u671f\u7814\u7a76\u7684\u5242\u91cf\u4f18\u5316\u548c\u5242\u91cf\u8ba1\u5212\u8003\u91cf\u3002<\/p>\n<p>\u4e0e FDA \u7684\u4f1a\u8bae\u5b9a\u4e8e\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u4e3e\u884c\uff0c\u5982\u679c\u7ed3\u679c\u662f\u6709\u5229\u7684\uff0c1b \u9636\u6bb5\u7814\u7a76\u548c\u6ce8\u518c\u9636\u6bb5 2 \u8bd5\u9a8c\u53ef\u4ee5\u5728 12 \u4e2a\u6708\u5185\u5f00\u59cb\u3002<\/p>\n<p>Prescient \u5c06\u63d0\u524d\u5f00\u5c55\u53e6\u4e00\u9879 PTX-100 \u5236\u9020\u6d3b\u52a8\uff0c\u4ee5\u4fc3\u8fdb\u8fdb\u4e00\u6b65\u7814\u7a76\u3002 \u4e3a\u4e86\u652f\u6301\u540e\u671f\u8bd5\u9a8c\u548c\u76d1\u7ba1\u63d0\u4ea4\uff0c\u5236\u9020\u8fc7\u7a0b\u5c06\u88ab\u4ed4\u7ec6\u8bb0\u5f55\u3002<\/p>\n<p>Prescient \u9996\u5e2d\u533b\u7597\u5b98 Terrence Chew \u535a\u58eb\u8868\u793a\uff0c\u4ed6\u5bf9\u5728\u96be\u4ee5\u6cbb\u7597\u7684\u60a3\u8005\u7fa4\u4f53\u4e2d\u53d6\u5f97\u7684\u4ee4\u4eba\u9f13\u821e\u7684\u7597\u6548\u548c\u5b89\u5168\u7684\u7ed3\u679c\u611f\u5230\u6ee1\u610f\u3002<\/p>\n<p>\u4e0e\u6b64\u540c\u65f6\uff0cPrescient \u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406 Steven Yatomi-Clarke \u8865\u5145\u8bf4\uff0cPTX-100\u5728\u590d\u53d1\u548c\u96be\u6cbb\u6027 T \u7ec6\u80de\u6dcb\u5df4\u7624\u4e2d\u4ee4\u4eba\u9f13\u821e\u7684\u4e34\u5e8a\u6570\u636e\u53ca\u5176\u51fa\u8272\u7684\u5b89\u5168\u6027\uff0c\u4e3a\u516c\u53f8\u548c\u6b63\u5728\u7b49\u5f85\u66f4\u6709\u6548\u7684\u7597\u6cd5\u7684 TCL \u60a3\u8005\u63d0\u4f9b\u4e86\u4e00\u4e2a\u4ee4\u4eba\u5174\u594b\u7684\u673a\u4f1a\u3002<\/p>\n<p>\u4ed6\u8bf4\uff1a\u201c\u770b\u5230 PTX-100 \u7684\u4e34\u5e8a\u6570\u636e\u7ee7\u7eed\u5982\u6b64\u6709\u5229\u5730\u5c55\u5f00\uff0c\u975e\u5e38\u4ee4\u4eba\u5174\u594b\uff0c\u5c24\u5176\u662f\u5728\u8fd9\u4e9b\u590d\u53d1\u548c\u96be\u6cbb\u6027 T \u7ec6\u80de\u6dcb\u5df4\u7624\u4e2d\uff0c\u8fd9\u4e9b\u80bf\u7624\u7279\u522b\u96be\u4ee5\u6cbb\u7597\uff0c\u800c\u4e14\u5176\u4ed6\u7597\u6cd5\u90fd\u5931\u8d25\u4e86\u3002\u201d<\/p>\n<p>\u8fd9\u662f\u7ee7 Prescient \u4e0a\u5468 <a href=\"http:\/\/smallcaps-production.test\/prescient-therapeutics-fda-orphan-drug-status-ptx-100-treat-t-cell-lymphomas\/?lang=cn\">PTX-100 \u4ece FDA \u83b7\u5f97\u6307\u5b9a\u7684\u5b64\u513f\u836f\u7269\u5f85\u9047\uff0c\u7528\u4e8e\u6cbb\u7597 T \u7ec6\u80de\u6dcb\u5df4\u7624<\/a> \u8fd9\u4e00\u7684\u6d88\u606f\u4e4b\u540e\u7684\u65b0\u6d88\u606f\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8 Prescient Therapeutics (ASX: PTX) \u5ba3\u5e03\u4e86\u9488\u5bf9\u590d\u53d1\u548c\u8010\u836f T \u7ec6\u80de\u6dcb\u5df4\u7624 (TCL) \u7684 PTX-100 1b \u671f\u6269\u5c55\u961f\u5217\u7684\u8fde\u7eed\u4e14\u79ef\u6781\u7684\u7ed3\u679c\u3002 \u8be5\u7814\u7a76\u7531\u58a8\u5c14\u672c Epworth \u533b\u9662\u7684\u8457\u540d\u8840\u6db2\u5b66\u5bb6 H Miles Prince \u6559\u6388\u9886\u5bfc\uff0c\u5df2\u8bc1\u660e\u5177\u6709\u826f\u597d\u7684\u4e34\u5e8a\u6d3b\u6027\u548c\u51fa\u8272\u7684\u5b89\u5168\u6027\u3002 \u81ea 2022 \u5e74 11 \u6708\u7684\u6700\u540e\u4e00\u6b21\u66f4\u65b0\u4ee5\u6765\uff0c\u5728\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624 (PTCL) \u60a3\u8005\u4e2d\u89c2\u5bdf\u5230\u4e24\u4e2a\u65b0\u7684\u5b8c\u5168\u53cd\u5e94\u3002 \u6b64\u5916\uff0c10 \u540d\u53ef\u8bc4\u4f30\u60a3\u8005\u4e2d\u6709 7 \u540d\u7684\u53cd\u5e94\u6301\u7eed\u65f6\u95f4\u8d85\u8fc7\u62a4\u7406\u6807\u51c6\uff0c\u5df2\u62a5\u544a\u7684\u5b89\u5168\u72b6\u51b5\u4ecd\u7136\u201c\u975e\u5e38\u597d\u201d\u3002 \u7814\u7a76\u6210\u679c PTX-100 \u5df2\u7528\u4e8e 13 \u540d TCL \u60a3\u8005\uff0c\u5176\u4e2d 8 \u540d\u60a3\u6709 PTCL\uff0c5 \u540d\u60a3\u76ae\u80a4 T \u7ec6\u80de\u6dcb\u5df4\u7624 (CTCL)\u3002 \u5728 2,000mg\/m2 \u7684\u6700\u9ad8\u5242\u91cf\u4e0b\uff0cPTX-100 \u7ee7\u7eed\u8868\u73b0\u51fa\u201c\u51fa\u8272\u7684\u5b89\u5168\u6027\u201d\uff0c\u4e25\u91cd\u4e0d\u826f\u4e8b\u4ef6\u6781\u5c11\u3002 \u4e00\u4e9b\u60a3\u8005\u51fa\u73b0\u4e86 3 \u7ea7\u4e0d\u826f\u4e8b\u4ef6\uff0c\u5305\u62ec\u4e2d\u6027\u7c92\u7ec6\u80de\u51cf\u5c11\u3001\u8840\u5c0f\u677f\u51cf\u5c11\u548c\u8d2b\u8840\uff0c\u8fd9\u53ef\u80fd\u4e0e PTX-100 \u6709\u5173\u3002 \u7136\u800c\uff0c\u8fd9\u4e9b\u4e0d\u826f\u4e8b\u4ef6\u5df2\u7ecf\u89e3\u51b3\u5e76\u4e14\u88ab\u8ba4\u4e3a\u662f\u53ef\u63a7\u7684\u3002&hellip; <a class=\"more-link\" href=\"https:\/\/smallcapscn.x5view.co\/?p=6548\">Continue reading <span class=\"screen-reader-text\">Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9<\/span><\/a><\/p>\n","protected":false},"author":5,"featured_media":18500,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[171],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9<\/title>\n<meta name=\"description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8 Prescient Therapeutics (ASX: PTX) \u5ba3\u5e03\u4e86\u9488\u5bf9\u590d\u53d1\u548c\u8010\u836f T \u7ec6\u80de\u6dcb\u5df4\u7624 (TCL) \u7684 PTX-100 1b \u671f\u6269\u5c55\u961f\u5217\u7684\u8fde\u7eed\u4e14\u79ef\u6781\u7684\u7ed3\u679c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9\" \/>\n<meta property=\"og:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8 Prescient Therapeutics (ASX: PTX) \u5ba3\u5e03\u4e86\u9488\u5bf9\u590d\u53d1\u548c\u8010\u836f T \u7ec6\u80de\u6dcb\u5df4\u7624 (TCL) \u7684 PTX-100 1b \u671f\u6269\u5c55\u961f\u5217\u7684\u8fde\u7eed\u4e14\u79ef\u6781\u7684\u7ed3\u679c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-16T02:48:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Prescient-Therapeutics-ASX-PTX-100-clinical-trial-results-T-cell-lymphoma-TCL.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/\",\"name\":\"Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-03-16T02:48:34+00:00\",\"dateModified\":\"2023-08-29T18:01:27+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8 Prescient Therapeutics (ASX: PTX) \u5ba3\u5e03\u4e86\u9488\u5bf9\u590d\u53d1\u548c\u8010\u836f T \u7ec6\u80de\u6dcb\u5df4\u7624 (TCL) \u7684 PTX-100 1b \u671f\u6269\u5c55\u961f\u5217\u7684\u8fde\u7eed\u4e14\u79ef\u6781\u7684\u7ed3\u679c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9","description":"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8 Prescient Therapeutics (ASX: PTX) \u5ba3\u5e03\u4e86\u9488\u5bf9\u590d\u53d1\u548c\u8010\u836f T \u7ec6\u80de\u6dcb\u5df4\u7624 (TCL) \u7684 PTX-100 1b \u671f\u6269\u5c55\u961f\u5217\u7684\u8fde\u7eed\u4e14\u79ef\u6781\u7684\u7ed3\u679c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9","og_description":"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8 Prescient Therapeutics (ASX: PTX) \u5ba3\u5e03\u4e86\u9488\u5bf9\u590d\u53d1\u548c\u8010\u836f T \u7ec6\u80de\u6dcb\u5df4\u7624 (TCL) \u7684 PTX-100 1b \u671f\u6269\u5c55\u961f\u5217\u7684\u8fde\u7eed\u4e14\u79ef\u6781\u7684\u7ed3\u679c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/","og_site_name":"smallcapsCN","article_published_time":"2023-03-16T02:48:34+00:00","article_modified_time":"2023-08-29T18:01:27+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Prescient-Therapeutics-ASX-PTX-100-clinical-trial-results-T-cell-lymphoma-TCL.jpg","type":"image\/jpeg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/","url":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/","name":"Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-03-16T02:48:34+00:00","dateModified":"2023-08-29T18:01:27+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8 Prescient Therapeutics (ASX: PTX) \u5ba3\u5e03\u4e86\u9488\u5bf9\u590d\u53d1\u548c\u8010\u836f T \u7ec6\u80de\u6dcb\u5df4\u7624 (TCL) \u7684 PTX-100 1b \u671f\u6269\u5c55\u961f\u5217\u7684\u8fde\u7eed\u4e14\u79ef\u6781\u7684\u7ed3\u679c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/prescient-therapeutics-ptx-100-promising-results-clinical-t-cell-lymphoma-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Prescient Therapeutics \u7684 PTX-100 \u5728\u4e34\u5e8a T \u7ec6\u80de\u6dcb\u5df4\u7624\u8bd5\u9a8c\u4e2d\u518d\u83b7\u4f73\u7ee9"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6548"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6548"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6548\/revisions"}],"predecessor-version":[{"id":20346,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6548\/revisions\/20346"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18500"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}